Therapeutic options for cutaneous leishmaniasis

被引:13
|
作者
Mahajan, Vikram K. [1 ]
Sharma, Nand Lal [1 ]
机构
[1] Indira Gandhi Med Coll, Dept Dermatol Venerol & Leprosy, Shimla 171001, Himachal Prades, India
关键词
amphotericin B; cutaneous leishmaniasis; dapsone; imidazoles; miltefosine; rifampicin; sodium stibogluconate;
D O I
10.1080/09546630601159474
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Cutaneous leishmaniasis occurs worldwide in both old and new world countries with their own endemic foci. Many of those infected often experience a delay in diagnosis and inappropriate treatment. Objectives: To review the literature in terms of the various treatment options described for cutaneous leishmaniasis. Methods: Literature on the treatment of cutaneous leishmaniasis retrieved by searching Index Medicus, PubMed and IndMed were reviewed. Results and conclusion: Review reveals no uniform pattern or definite guidelines for its therapy. The varied and contradictory experience of different workers further confounds the clinicians involved in the care of these patients. Selection of an appropriate and customized treatment schedule is a discretion the treating clinician has to make.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [1] Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis
    Begoña Monge-Maillo
    Rogelio López-Vélez
    Drugs, 2013, 73 : 1889 - 1920
  • [2] Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis
    Lafleur, Andrea
    Daffis, Stephane
    Mowbray, Charles
    Arana, Byron
    VACCINES, 2024, 12 (10)
  • [3] Cutaneous leishmaniasis - treatment options in children
    Matin, R. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (04) : 844 - 845
  • [4] Cutaneous leishmaniasis: therapeutic strategies and future directions
    Ameen, Mahreen
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (16) : 2689 - 2699
  • [5] Perceptions on therapeutic modalities regarding the virulence and immunity of cutaneous leishmaniasis
    Saftawy, Enas A. El
    Hamed, Ahmed A.
    Sameh, Ahmed
    Sarhan, Rania M.
    PARASITOLOGISTS UNITED JOURNAL, 2021, 14 (03) : 229 - 243
  • [6] Cutaneous Leishmaniasis Updates in Diagnosis and Management
    Aronson, Naomi E.
    Joya, Christie A.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (01) : 101 - +
  • [7] Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review
    Azim, Marium
    Khan, Saeed Ahmad
    Ullah, Saleem
    Ullah, Shafiq
    Anjum, Syed Ishtiaq
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (03):
  • [8] Therapeutic effect of topical tamoxifen in murine cutaneous leishmaniasis caused by Leishmania major
    Hassani-Abharian, Parastoo
    Dehaghani, Seyedamirmehdi Hejazi
    Shahmoradi, Zabihollah
    Hejazi, Seyed Hossein
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (12)
  • [9] MILTEFOSINE IN CUTANEOUS LEISHMANIASIS
    Rahman, Simeen Ber
    ul Bari, Arlan
    Mumtaz, Nadeem
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2007, 17 (03): : 132 - 135
  • [10] Miltefosine and cutaneous leishmaniasis
    Machado, Paulo R. L.
    Penna, Gerson
    CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (02) : 141 - 144